Hepatitis C

Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study

Regimens that contain sofosbuvir (SOF) or simeprevir (SIM) are highly effective for treating chronic hepatitis C virus (HCV) infection. These regimens, however, are expensive. Most payers have implemented prior authorization (PA) requirements to ensure that patients who can benefit most have priority for these medications.

Subscribe to RSS - Hepatitis C